EFFECTIVENESS OF LIPIODOL IN TRANSCATHETER ARTERIAL EMBOLIZATION OF HEPATOCELLULAR-CARCINOMA

被引：18

作者：

NAKAO, N

UCHIDA, H

KAMINO, K

NISHIMURA, Y

OHISHI, H

TAKAYASU, Y

NAKAMURA, H

KURODA, C

FUJITA, M

YOSHIOKA, H

ISHIDA, O

机构：

[1] NARA MED UNIV,DEPT RADIOL,KASHIHARA,NARA 634,JAPAN

[2] OSAKA UNIV,SCH MED,DEPT RADIOL,OSAKA,JAPAN

[3] CTR ADULT DIS,DEPT RADIOL,OSAKA 537,JAPAN

[4] KINKI UNIV,SCH MED,DEPT RADIOL,OSAKA,OSAKA 577,JAPAN

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1992年 / 31卷

关键词：

HEPATOCELLULAR CARCINOMA; TRANSCATHETER ARTERIAL EMBOLIZATION; LIPIODOL (IODIZED OIL);

D O I：

10.1007/BF00687110

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The effectiveness of Lipiodol (iodized oil) in transcatheter arterial embolization (TAE) of hepatocellular carcinoma (HCC) was retrospectively evaluated using statistical analysis. A total of 343 HCC patients who underwent TAE at 5 institutions between 1984 and 1989 were divided into 2 groups: the GS-TAE group underwent TAE with Gelfoam sponge alone, whereas the LP-TAE group was given Lipiodol (LP) immediately before GS-TAE. The statistical T value calculated for the LP-TAE group showed that the administration of LP, the tumor size, intrahepatic metastasis, portal vein infiltration, and serum total bilirubin and alpha-fetoprotein levels significantly (P <0.01) affected the patients' survival. Both the cumulative survival determined using the Kaplan-Meier model and the cumulative hazard calculated using Cox's proportional hazard model differed significantly (P <0.01) between the GS-TAE group and the LP-TAE group (log-rank test). These results confirmed the effectiveness of LP used in combination with Gelfoam sponge for TAE of HCC.

引用

页码：S72 / S76

页数：5

共 18 条

[1]

BEERS BV, 1989, ACTA RADIOL, V30, P415

[2] HEPATIC-ARTERY EMBOLIZATION IN THE TREATMENT OF HEPATIC NEOPLASMS [J].